Home
NewsNewsTest tube baby treatment will begin at the Castle Street Hospital, expanding IVF access in public healthcare system of Sri Lanka for couples facing infertility and marking a new chapter in the reproductive health services of the nation.
Sri Lanka introduces test tube baby treatment at the Castle Street Hospital for Women in Colombo, marking the first time IVF services will be offered through a government hospital.
The official said this facility would mean that in vitro fertilization, or IVF, would be available under the public healthcare sector. Till date, fertility treatments have been limited to private hospitals only. He added that this will help couples who cannot afford expensive treatments at private hospitals.
Director of the Castle Street Hospital for Women, Dr. Ajith Kumara Danthanarayana said the facility is nearing readiness.
“The new facility is expected to be operational within the next three months. This is an important step in providing advanced reproductive health services through the public healthcare system,”
“Our aim is to ensure that couples who cannot afford expensive private treatment are given a fair opportunity to fulfill their dream of parenthood,” he said.
At present, test tube baby treatment in Sri Lanka is available only at a small number of private hospitals, where a single IVF cycle typically costs between Rs. 2 million and Rs. 3 million.
IVF is a procedure in which an egg is fertilized with sperm outside the body in a lab and then put into the uterus. IVF treatment is being performed to overcome infertility caused by blocked fallopian tubes, low sperm count, an imbalance of hormones, or even unknown causes.
Doctors said that initiating an IVF facility in a government hospital will be a welcome step, as increasing numbers of couples are suffering from infertility problems and facing mental trauma for not being able to access treatment.
Technology-Enabled Cryostorage is transforming fertility storage as Reprotech and TMRW combine expertise in digital specimen management and biorepository services. The partnership enhances scalability, safety, and efficiency while supporting clinics with advanced solutions. This strategic move positions the combined company to lead innovation and meet growing global demand in cryostorage services.
First AI-powered egg-freezing program has been initiated by Sunfish with an intent to get rid of uncertainty within the fertility preservation space, offering personalised insights and higher success predictability for women.
3billion has gone on to launch the Family Insight Test using WES and WGS analysis aimed at targeting couples who cannot get pregnant for no apparent reason, helping them discover hidden genetic factors affecting fertility.
Arbor Fertility™ with 8 locations in Missouri & Illinois has designed a streamlined patient-centred approach leading to Affordable, Accessible Fertility Care, making high-quality treatment available without financial burden.
BGI Genomics, a Chinese biotechnology company is working on AI-Powered Chromosome Screening Tools so as to accelerate and enhance IVF treatments in China, aiming to reduce genetic abnormalities and increase live birth outcomes.
Before taking a call on IVF, survey conducted in the U.S., UK, Ireland, and Canada suggests that people are looking for complete & less expensive options to treat root causes of infertility.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
